Seven established research teams at four Austrian universities are studying lipid hydrolases, which are key enzymes for cell growth and proliferation, cellular signal transduction, and energy metabolism. Therefore, dysfunctions of these lipid hydrolases are often causes of many metabolic diseases. With research teams that understand the structure, function and physiological relevance of lipid hydrolases, the SFB LIPID HYDROLYSIS aims to contribute to the elucidation of pathogenic mechanisms and the development of new, innovative treatment strategies. All researchers involved in the SFB have access to the six technology platforms. In addition, new research findings of the interdisciplinary teams are discussed in a continuous scientific exchange with the members of the scientific advisory board.